Please login to the form below

Not currently logged in
Email:
Password:

Federal Trade Commission

This page shows the latest Federal Trade Commission news and features for those working in and with pharma, biotech and healthcare.

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

The Federal Trade Commission (FTC) and Department of Justice (DoJ) said this week that they were implementing an expedited antitrust procedure to make it easier for companies to work together on

Latest news

More from news
Approximately 3 fully matching, plus 62 partially matching documents found.

Latest Intelligence

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    The Federal Trade Commission (FTC), which has broad powers to regulate business practices, estimates these anti-competitive deals cost consumers $3.5bn a year, and they delay the availability of ... New and complex. In his BAP remarks, Gottlieb said the

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Pipeline problems. The Commission’s novel approach has its roots in pharma mergers. ... In the US, the Federal Trade Commission (FTC) has followed a similar approach.

  • Deal Watch June 2016 Deal Watch June 2016

    Three of the deals were focused on the requirement of Teva and Allergan to divest assets to satisfy the regulators and obtain clearance from the US Federal Trade Commission for

  • Pharma deals in May 2015 Pharma deals in May 2015

    The product has been the subject of an investigation from the US Federal Trade Commission (FTC) and although not usually reported in Deal Watch, the $1.2bn settlement is noteworthy recognising ... Watch this space! PRVs. Finally, we noted in the Annual

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics